GUANETHIDINE MONOSULFATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for guanethidine monosulfate and what is the scope of patent protection?
Guanethidine monosulfate
is the generic ingredient in three branded drugs marketed by Watson Labs and Novartis, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for guanethidine monosulfate.
Summary for GUANETHIDINE MONOSULFATE
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 2 |
| NDAs: | 4 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Patent Applications: | 593 |
| DailyMed Link: | GUANETHIDINE MONOSULFATE at DailyMed |
Medical Subject Heading (MeSH) Categories for GUANETHIDINE MONOSULFATE
Anatomical Therapeutic Chemical (ATC) Classes for GUANETHIDINE MONOSULFATE
US Patents and Regulatory Information for GUANETHIDINE MONOSULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | ISMELIN | guanethidine monosulfate | TABLET;ORAL | 012329-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | GUANETHIDINE MONOSULFATE | guanethidine monosulfate | TABLET;ORAL | 086114-001 | Mar 26, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | ISMELIN | guanethidine monosulfate | TABLET;ORAL | 012329-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | GUANETHIDINE MONOSULFATE | guanethidine monosulfate | TABLET;ORAL | 086113-001 | Mar 26, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
